Here's what to know about the new mRNA flu vaccine

The FDA has approved Moderna’s new flu vaccine, which utilizes mRNA technology. This represents the first mRNA flu vaccine to receive authorization from the Food and Drug Administration. According to reports by Dr. Céline Gounder, this technological advancement enables a more rapid response in targeting particularly virulent or widely prevalent strains of the virus. The approval facilitates the use of mRNA to improve the speed and efficiency of vaccine development against evolving influenza threats.